This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Susan Hoe: Innovator in Thymic Stromal Lymphopoietin Research
Introduction
Susan Hoe is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic formulations. With a total of 2 patents, her work focuses on innovative solutions for treating asthma.
Latest Patents
Susan Hoe's latest patents include groundbreaking technologies related to dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies. These patents detail methods of treating asthma using these dry powder formulations, which are designed for pulmonary delivery. The technology aims to improve the efficacy of asthma treatments by utilizing specific antibodies that target TSLP.
Career Highlights
Throughout her career, Susan has demonstrated a commitment to advancing medical science. Her work at Medimmune Limited has positioned her as a key player in the development of novel therapeutic approaches. Her innovative research has the potential to significantly impact the treatment of respiratory conditions.
Collaborations
Susan Hoe has collaborated with notable colleagues, including Catherine Eugenie Chaillan Huntington and Prakash Manikwar. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.
Conclusion
Susan Hoe's contributions to the field of asthma treatment through her innovative patents highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic formulations, showcasing the importance of innovation in healthcare.